 |
|
 |
Profit & Loss |
 |
|
2022/12 - Final HKD($) | %Chg (Final to Final) | 2021/12 HKD($) | 2020/12 HKD($) |
Turnover | 184,683,000 | 30.477% | 141,544,000 | 88,223,000 | Cost of Sales | -- | -- | -- | -- | Gross Profit | -- | -- | -- | -- | Change in FV & Impairment on Inv. Prop. | (2,028,000) | 29.668% | (1,564,000) | (3,209,000) | Change in FV & Impairment on Others | 450,000 | -- | (412,000) | (8,227,000) | Profit / (Loss) on Disposal | 9,426,000 | -35.216% | 14,550,000 | 55,197,000 | Other Non-operating Items | -- | -- | -- | (907,000) | Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | Profit / (Loss) before Taxation | (8,311,000) | 73.363% | (4,794,000) | 8,851,000 | Taxation | (3,509,000) | 40.080% | (2,505,000) | 251,000 | Profit / (Loss) from Discontinued Operations | -- | -- | (960,000) | -- | Non-controlling Interests | 1,965,000 | 517.925% | 318,000 | 1,177,000 | Others | -- | -- | -- | -- | Profit / (Loss) Attributable to Shareholders | (9,855,000) | 24.103% | (7,941,000) | 10,279,000 | Net Finance Costs / (Income) | 3,526,000 | 47.346% | 2,393,000 | 1,869,000 | Depreciation & Amortisation | 17,685,000 | -2.760% | 18,187,000 | 12,489,000 | Directors' Emoluments | -- | -- | 4,160,000 | 3,130,000 | Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | | Market Valuation Indicators | EPS (cts) | -1.000 | -% | -0.800 | 1.000 | DPS (cts) | 0.000 | -- | 0.000 | 0.000 | Dividend Payout Ratio (%) | -- | -- | -- | -- | Cash flow per share ($) | -- | -- | -0.016 | -0.016 | NBV per share ($) | 0.279 | -% | 0.316 | 0.314 |
|
|
 |
|
|
 |